Abstract LB-238: Integrated genomic (TCGA & Validation Set) & pathway analysis in GBMs/MGs: the neurotrophin receptor (p75) mediates proliferation & invasion of GBMs & brain tumor initiating cells (BTICs).
Xiaotao Qu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Peter Forsyth(Moffitt Cancer Center), Ya-Yu Tsai(Moffitt Cancer Center), Rajappa S. Kenchappa(Mayo Clinic in Florida), Anders Berglund(Moffitt Cancer Center), Ann chen(Moffitt Cancer Center), Sarah E. Aiyar(Moffitt Cancer Center)
Cited by 0
Related Papers
Nivolumab in metastatic urothelial carcinoma after platinum therapy (CheckMate 275): a multicentre, single-arm, phase 2 trial
|The Lancet Oncology|2017|1.8k
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial
|Journal of Clinical Oncology|2020|1.3k
Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk
|PLoS ONE|2015|906
Abbreviated Course of Radiation Therapy in Older Patients With Glioblastoma Multiforme: A Prospective Randomized Clinical Trial
|Journal of Clinical Oncology|2004|888